Statistics for Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation.
Total visits
views | |
---|---|
Improved nonclinical pharmacokinetics and biodistribution of a new PPAR pan-agonist and COX inhibitor in nanocapsule formulation. | 98 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
ARTIGO_ImprovedNoclinicalPharmacokinetics.pdf(legacy) | 250 |
ARTIGO_ImprovedNoclinicalPharmacokinetics.pdf | 179 |
Top country views
views | |
---|---|
United States | 53 |
Germany | 29 |
Netherlands | 27 |
Brazil | 17 |
Vietnam | 13 |
China | 10 |
Singapore | 8 |
Russia | 7 |
France | 3 |
United Kingdom | 3 |
Argentina | 2 |
Sweden | 2 |
Czechia | 1 |
Greece | 1 |
India | 1 |
Ukraine | 1 |
Top city views
views | |
---|---|
Hanoi | 13 |
Ashburn | 10 |
Ningbo | 7 |
Mountain View | 6 |
Kaluga | 5 |
Shenzhen | 3 |
Santa Luzia | 2 |
Washington | 2 |
Athens | 1 |
Ceska | 1 |
Chicago | 1 |
Fremont | 1 |
Leawood | 1 |
Nyköping | 1 |
Oakland | 1 |
Phoenix | 1 |
Pune | 1 |
Salvador | 1 |
Sunnyvale | 1 |